Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1926 studies found for:    "rheumatoid arthritis"
Show Display Options
Rank Status Study
21 Completed A 12-week Study of 4 Doses of VX-509 in Subjects With Active Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: Placebo;   Drug: VX-509
22 Completed
Has Results
A Study of Adalimumab in Japanese Subjects With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Biological: Double-blind adalimumab;   Drug: Double-blind Placebo;   Biological: Open-label Adalimumab;   Biological: Open-labelAdalimumabRescue
23 Completed Study Evaluating the Combination of Etanercept and Methotrexate in Rheumatoid Arthritis Subjects
Condition: Rheumatoid Arthritis
Interventions: Drug: Etanercept;   Drug: Methotrexate
24 Terminated
Has Results
A Long Term Study to Assess the Safety of Fostamatinib in Patients in Asia With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: Fostamatinib
25 Completed Special Investigation in Patients With Rheumatoid Arthritis (Working Productivity Activity Impairment)
Condition: Rheumatoid Arthritis
Intervention:
26 Completed Study Evaluating ERB-041 With Methotrexate in Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: Methotrexate plus ERB-041 for 12 weeks;   Drug: Placebo for 12 weeks
27 Unknown  A Study of Two Doses of MRC375 in Moderate to Severe Rheumatoid Arthritis Patients
Condition: Rheumatoid Arthritis
Interventions: Drug: MRC375;   Drug: Matching Placebo;   Drug: MRC375 150mg
28 Recruiting Rheumatoid Arthritis Patients and Porphyromonas Gingivalis
Condition: Rheumatoid Arthritis
Interventions: Procedure: blood sample;   Procedure: synovial tissue
29 Active, not recruiting Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of VAY736 in Rheumatoid Arthritis Patients
Condition: Rheumatoid Arthritis
Interventions: Biological: VAY736;   Biological: VAY736 placebo
30 Completed Safety, Tolerability, and Pharmacodynamic Study of ISIS CRP Rx in Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: ISIS CRP Rx or Placebo
31 Completed
Has Results
Efficacy and Safety Study of MP-435 in Combination With Methotrexate (MTX) in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: MP-435(dose1) + Methotrexate;   Drug: Placebo + Methotrexate
32 Completed A Study Evaluating 10 mg and 25 mg Doses of Etanercept in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: etanercept
33 Completed
Has Results
Study Comparing Etanercept and Methotrexate vs. Methotrexate Alone in Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: Etanercept;   Drug: Methotrexate;   Drug: Placebo
34 Completed Study of Human Leukocyte Antigen (HLA) Polymorphisms in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Biological: Collect of 10 ml of peripheric blood for DNA extraction
35 Completed A Study of Tocilizumab in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention:
36 Completed
Has Results
A Study Exploring the Safety, Tolerability and Efficacy of a 4 Week Course of INCB018424 in Subjects With Active Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: INCB018424;   Drug: Placebo
37 Completed
Has Results
Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate.
Condition: Rheumatoid Arthritis
Interventions: Biological: Adalimumab;   Drug: Placebo
38 Completed
Has Results
Special Investigation in Patients With Rheumatoid Arthritis (HOPEFUL III Study), a Follow-up Survey of Study P12-069
Condition: Rheumatoid Arthritis
Intervention:
39 Completed Physical Activity Behavior of Rheumatoid Arthritis Patients and Healthy Controls
Condition: Rheumatoid Arthritis
Intervention:
40 Completed
Has Results
Assessment of the Safety of Adalimumab in Rheumatoid Arthritis Patients Showing Rapid Progression of Structural Damage of the Joints, Who Have no Prior History of Treatment With Disease-modifying Anti-rheumatic Drugs or Biological Agents
Condition: Rheumatoid Arthritis
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.